AstraZeneca-Oxford vaccine trial volunteer dies in Brazil, tests to continue
Coronavirus vaccine update: A volunteer in Brazil's clinical trials of a coronavirus vaccine developed by AstraZeneca AZN.L and Oxford University has died, Brazilian health authority Anvisa said on Wednesday. However, the testing of AstraZeneca-Oxford's coronavirus vaccine, the regular said, would continue.
The AstraZeneca coronavirus vaccine volunteer who died was a Brazilian, Federal University of Sao Paulo said. The Brazilian health authority did not provide any more details, citing the confidentiality of the volunteers involved in trials of the AstraZeneca coronavirus vaccine but said it had received data from an investigation into the matter.
After the reports of a coronavirus vaccine volunteer dying started doing the rounds, AstraZeneca shares turned negative and went down 1.7 percent.
Brazil has the second deadliest outbreak of coronavirus, with more than 155,000 killed by the coronavirus infection, following only the United States. It is the third-worst outbreak in terms of cases, with more than 5.2 million infected, after the United States and India.
Brazil reached 1 million cases in June and now is up to 5.2 million for the pandemic.